Some states now allow dispensing of oral anticancer medications via practice-based pharmacies. In this segment, Michael Kolodziej, MD, and Ted Okon, MBA, consider the impact of establishing a dispensing pharmacy within a practice.
Dr Kolodziej remarks that although these pharmacies permit patients to receive their medications at their doctor’s office, barriers and concerns including prior authorizations, co-payment costs, and patient adherence remain. Additionally, small practices are not able to negotiate with payers for volume discounts. Comparative effectiveness research could play an important role in addressing some of these issues, suggests Dr Kolodziej.
Many practices have reached out to the Community Oncology Alliance (COA) looking for support and information about operating pharmacies within their practices, notes Mr Okon. To assist practices, the COA recently established the Community Oncology Pharmacy Association to help establish quality standards, among other goals.
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
November 20th 2024Professional guidelines say that when pulmonary arterial hypertension (PAH) is diagnosed, right heart catheterization should be performed, but a quarter of the time, it isn’t—so investigators set out to discover why.
Read More